On Monday I was finally able to start the clinical trial Everolimus for patients with relapsed/refractory germ cell cancer (RADIT), and I’m now looking forward to recruit the first patient. We aim to treat 25 patients with cancer of the testis with the mTOR inhibitor everolimus in this phase II trial, and eight German hospitals are participating.
The International Committee of Medical Journal Editors (ICMJE) requires, as a condition of consideration for publication in their journals, registration in a public trials registry. I registered my trial with Clinicaltrials.gov as NCT01242631. The registration process was straightforward, especially compared to all the other paperwork required for this trial.
The requirement for registration of clinical trials helps to prevent publication bias – meaning that negative results are likely to never be published. Clinical trial registries make it unlikely that you will be “scooped”, as you know about the other studies addressing the same questions years before they finish.
Eating your own Dog Food
Eating your own dog food is a slang term to describe that an organization should itself use the products and services it provides. For DataCite this means that we should use DOIs with appropriate metadata and strategies for long-term preservation for the scholarly outputs we produce. ...
Making the most out of available Metadata
Metadata are essential for finding, accessing, and reusing scholarly content, i.e. to increase the FAIRness [Wilkinson et al. (2016)] of datasets and other scholarly resources. A rich and standardized metadata schema that is widely used is the first step, ...
2020 Strategic Priorities for Services and Infrastructure
In a blog post four weeks ago DataCite Executive Director Matt Buys talked about the DataCite strategic priorities for 2020 (Buys, 2020). In this post we want to talk a bit more about the strategic priorities for this year we have regarding services and infrastructure work: a) ...